Table 1.
Cohort 1 (n = 1379) | Cohort 2 (n = 591) | Cohort 3 (n = 96) | Cohort 4 (n = 211) | |
---|---|---|---|---|
Data source | India | India | India | USA |
Age, years | 62.4 (23–92) | 61.7 (21–90) | 58.6 (24–86) | 67.96 (24–87) |
Sex | ||||
Male | 905 (65.6%) | 356 (60.2%) | 64 (66.7%) | 135 (63.9%) |
Female | 474 (34.4%) | 235 (39.8%) | 32 (33.3%) | 76 (36.1%) |
Smoking | ||||
Never | 736 (54.4%) | 356 (60.2%) | 67 (69.8%) | 48 (22.7%) |
Smoker | 643 (46.6%) | 235 (39.8%) | 29 (30.2%) | 163 (77.3%) |
Histology | ||||
Adenocarcinoma | 903 (65.5%) | 408 (69.0%) | 93 (96.9%) | 172 (81.5%) |
Squamous cell carcinoma | 259 (18.8%) | 101 (17.1%) | 3 (3.1%) | 35 (16.6%) |
Others | 217 (15.7%) | 82 (13.9%) | 0 (0.0%) | 4 (1.9%) |
EGFR genotype | ||||
Wild-type | 699 (50.7%) | 286 (48.4%) | 69 (71.9%) | 133 (63%) |
Mutant | 680 (49.3%) | 305 (51.6%) | 25 (28.1%) | 38 (18%) |
NA | 0 | 0 | 0 | 40 (19%) |
The patient characteristics are unavailable for Cohort 5.